Prostaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathways
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Although the lipid mediator prostaglandin E(2) (PGE(2)) exerts antifibrotic effects by inhibiting multiple fibroblast functions, its ability to regulate fibroblast survival is unknown. Here, we examined the effects of this prostanoid on apoptosis and apoptosis pathways in normal and fibrotic lung fibroblasts. As compared to medium alone, 24 h of treatment with PGE(2) increased apoptosis of normal lung fibroblasts in a dose-dependent manner (EC(50) approximately 50 nM), as measured by annexin V staining, caspase 3 activity, cleavage of poly-ADP-ribose polymerase, and single-stranded DNA levels. PGE(2) also potentiated apoptosis elicited by Fas ligand plus cycloheximide. These proapoptotic actions were dependent on signaling through the EP2/EP4 receptors and by downstream activation of both caspases 8 and 9. Silencing and gene deletion of PTEN demonstrated that the effects of PGE(2) involved decreased activity of the prosurvival molecule Akt. PGE(2) also down-regulated expression of survivin, an inhibitor of apoptosis, and increased expression of Fas. Fibroblasts from patients with pulmonary fibrosis exhibited resistance to the apoptotic effects of PGE(2). These findings show for the first time that, in contrast to its effects on many other cell types, PGE(2) promotes apoptosis in lung fibroblasts through diverse pathways. They provide another dimension by which PGE(2) may inhibit, and perhaps even reverse, fibrogenesis in patients with interstitial lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 has similar effects on formation and apoptosis in lung and keloid fibroblasts (145–147).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [145]
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“PIP3 is a lipid mediator that recruits and activates proteins with pleckstrin homology domains such as Akt, which has been shown to be an important prosurvival mediator (41) that can inhibit both the intrinsic (42) and extrinsic (43) apoptotic pathways.”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · cited 3×
“PTEN is a lipid phosphatase that antagonizes the phosphatidylinositol-3-kinase (PI3K) pathway by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PIP3) (40).”
BackgroundMitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103 · cited 1×
“with activation of the apoptosome complex containing caspase 9, which leads to further cleavage of downstream effector caspases 3, 6, and 7 (35).”
BackgroundRegulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481 · cited 1×
“PIP3 is a lipid mediator that recruits and activates proteins with pleckstrin homology domains such as Akt, which has been shown to be an important prosurvival mediator (41) that can inhibit both the intrinsic (42) and extrinsic (43) apoptotic pathways.”
BackgroundSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Desmoulière, A., Redard, M., Darby, I. A., & Gabbiani, G. (1995) · Europe PMC (PubMed Central) · Cited by 1,448
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326 · cited 1×
“, Fas), which, in turn, triggers the formation of the death-induced signaling complex, which leads to activation of caspase 8 (36, 37); activated caspase 8 further cleaves downstream effector caspases.”
BackgroundModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,236
Research works printed but not linked: 2
- 10.1172/jci22218 · doi:10.1172/jci22218 · Paper page
- 10.1002/(sici)1521-4141(199907)29:07<2360::aid-immu2360>3.0.co;2-a · doi:10.1002/(sici)1521-4141(199907)29:07<2360::aid-immu2360>3.0.co;2-a
Cited by
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Diverse functions of matrix metalloproteinases during fibrosis
Giannandrea, M., & Parks, W. C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012062 · Cited by 541
“PGE2 suppresses fibrosis by inhibiting fibroblast migration, proliferation, collagen synthesis and differentiation into myofibroblasts (Huang et al., 2009; Kolodsick et al., 2003; White et al., 2005).”
BackgroundMatrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
Diminished Prostaglandin E 2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
Maher, T. M., Evans, I. C., Bottoms, S. E., Mercer, P. F., Thorley, A. J., Nicholson, A. G., Laurent, G. J., Tetley, T. D., Chambers, R. C., & McAnulty, R. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0674oc · Cited by 196
cAMP and Epac in the regulation of tissue fibrosis
Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175
“…2005; 2010 Rat pulmonary fibroblasts, murine pulmonary fibroblasts Stumm et al., 2011 Murine lung fibroblasts Promotion of cell death of fibroblasts Huang et al., 2009 Human fetal lung fibroblast cell line IMR-90, primary human lung fibroblasts Insel et al., 2012b Various Zhang et al., 2011 Rat…”
BackgroundLipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
Suryadevara, V., Ramchandran, R., Kamp, D. W., & Natarajan, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124257 · Cited by 165
“Further, the ability of PGE2 to promote normal fibroblast apoptosis requires signaling through EP2/EP4 and reduction in protein kinase B (Akt) [63].”
BackgroundSisson, T. H., Ajayi, I. O., Subbotina, N., Dodi, A. E., Rodansky, E. S., Chibucos, L. N., Kim, K. K., Keshamouni, V. G., White, E. S., Zhou, Y., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.12.005 · Cited by 158
Self-citationE-type prostanoid receptor 4 (EP4) in disease and therapy
Konya, V., Marsche, G., Schuligoi, R., & Heinemann, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.006 · Cited by 158
Structural features of subtype-selective EP receptor modulators
Markovič, T., Jakopin, Ž., Dolenc, M. S., & Mlinarič-Raščan, I. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.003 · Cited by 159
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Predicting bulk mechanical properties of cellularized collagen gels using multiphoton microscopy
Raub, C. B., Putnam, A. J., Tromberg, B. J., & George, S. C. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.004 · Cited by 150
Huang, S. K., Scruggs, A. M., Donaghy, J., Horowitz, J. C., Zaslona, Z., Przybranowski, S., White, E. S., & Peters-Golden, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.146 · Cited by 147
Self-citationHuang, S. K., Fisher, A. S., Scruggs, A. M., White, E. S., Hogaboam, C. M., Richardson, B. C., & Peters-Golden, M. L. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100446 · Cited by 152
Self-citationMechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Self-citationProstaglandin E2 and the Pathogenesis of Pulmonary Fibrosis
Bozyk, P. D., & Moore, B. B. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0025rt · Cited by 152
Reversal of Myofibroblast Differentiation by Prostaglandin E2
Garrison, G. W., Huang, S. K., Okunishi, K., Scott, J. P., Penke, L. R. K., Scruggs, A. M., & Peters-Golden, M. L. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0262oc · Cited by 126
Self-citationFOXM1 is a critical driver of lung fibroblast activation and fibrogenesis
Penke, L. R. K., Speth, J. M., Dommeti, V. L., White, E. S., Bergin, I. L., & Peters-Golden, M. L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci87631 · Cited by 126
Self-citationMatrix Metalloproteinase-19 Is a Key Regulator of Lung Fibrosis in Mice and Humans
Yu, G., Kovkarova-Naumovski, E., Jara, P., Parwani, A., Kass, D., Ruiz, V., Lopez-Otín, C., Rosas, I. O., Gibson, K. F., Cabrera, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0302oc · Cited by 116
Chang, W., Wei, K., Jacobs, S. S., Upadhyay, D., Weill, D., & Rosen, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025684 · Cited by 113
Huang, S. K., Scruggs, A. M., McEachin, R. C., White, E. S., & Peters-Golden, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107055 · Cited by 93
“MGMT is a DNA repair enzyme that regulates chromatin stability and susceptibility to apoptosis [38] and its increased expression in IPF cells may contribute to the well-recognized phenomenon of fibroblast resistance to apoptosis in IPF [3,9,10,12].”
BackgroundSelf-citationCracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Guo, S. (2022) · Reproduction · doi:10.1530/rep-22-0224 · Cited by 100
Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis
Li, Y., Liang, J., Yang, T., Monterrosa Mena, J., Huan, C., Xie, T., Kurkciyan, A., Liu, N., Jiang, D., & Noble, P. W. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.03.004 · Cited by 93
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, E. R., Hashemi, F., Makvandi, P., Samarghandian, S., Khan, H. Z., Hashemi, F., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585413 · Cited by 87
“The prostaglandin E2 (PGE2) is formed by cyclooxygenase metabolism of arachidonic acid and inhibits the migration and proliferation of myofibroblasts, and ECM accumulation (Elias et al., 1985; Bitterman et al., 1986; Fine et al., 1989; Kolodsick et al., 2003; White et al., 2005; Huang et al., 2009).”
BackgroundProstaglandin E2protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction
Dackor, R. T., Cheng, J., Voltz, J. W., Card, J. W., Ferguson, C. D., Garrett, R. C., Bradbury, J. A., DeGraff, L. M., Lih, F. B., Tomer, K. B., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00176.2011 · Cited by 90
p53: A Key Protein That Regulates Pulmonary Fibrosis
Wu, Q., Zhang, K.-J., Jiang, S.-M., Fu, L., Shi, Y., Tan, R.-B., Cui, J., & Zhou, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6635794 · Cited by 78
“Hence, COX-2 plays a protective role in pulmonary fibrosis and can inhibit its progression [62, 63].”
BackgroundSurvivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis
Horowitz, J. C., Ajayi, I. O., Kulasekaran, P., Rogers, D. S., White, J. B., Townsend, S. K., White, E. S., Nho, R. S., Higgins, P. D. R., Huang, S. K., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.011 · Cited by 78
“Apoptosis assessments Apoptosis was assessed by Western blotting for cleaved PARP as the primary assay (Huang et al., 2009) and by ELISA-based detection of histone-associated DNA fragments using the Cell Death Detection ELISA Kit (Roche Applied Science, Indianapolis IN) according to the…”
BackgroundMethodSelf-citationX-Linked Inhibitor of Apoptosis Regulates Lung Fibroblast Resistance to Fas-Mediated Apoptosis
Ajayi, I. O., Sisson, T. H., Higgins, P., Booth, A. J., Sagana, R. L., Huang, S. K., White, E. S., King, J. E., Moore, B. B., & Horowitz, J. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0224oc · Cited by 81
“Additional studies show that Fas-induced apoptosis can be enhanced through inhibition of new protein synthesis with cycloheximide (10, 11, 35).”
InfluentialSelf-citationCombined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer
Gong, J., Xie, J., Bedolla, R. G., Rivas, P., Chakravarthy, D., Freeman, J. W., Reddick, R. L., Kopetz, S., Peterson, A., Wang, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1664 · Cited by 81
Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation
Wettlaufer, S. H., Scott, J. P., McEachin, R. C., Peters-Golden, M. L., & Huang, S. K. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0468oc · Cited by 76
Self-citationParks, B. W., Black, L. L., Zimmerman, K. A., Metz, A. E., Steele, C., Murphy-Ullrich, J. E., & Kabarowski, J. H. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035352 · Cited by 68
The Roles of Various Prostaglandins in Fibrosis: A Review
Li, K., Zhao, J., Wang, M., Niu, L., Wang, Y., Li, Y., & Zheng, Y. (2021) · Biomolecules · doi:10.3390/biom11060789 · Cited by 71
“However, PGE2 restores the sensitivity of fibroblasts to apoptosis and promotes apoptosis by activating the EP2/EP4 receptor through an increase in phosphatase and tensin homolog on chromosome ten (PTEN) activity, decrease in Akt activity and increase in Fas receptor expression [43].”
BackgroundWynes, M. W., Edelman, B. L., Kostyk, A. G., Edwards, M. G., Coldren, C., Groshong, S. D., Cosgrove, G. P., Redente, E. F., Bamberg, A., Brown, K. K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100447 · Cited by 68
“Two recent studies have shown a similar sensitizing effect of PGE2 on Fas-induced fibroblast apoptosis (14, 21).”
BackgroundApoptosis and eryptosis: similarities and differences
Tkachenko, A. S. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01915-4 · Cited by 71
Sisson, T. H., Christensen, P. J., Muraki, Y., Dils, A. J., Chibucos, L., Subbotina, N., Tohyama, K., Horowitz, J. C., Matsuo, T., Bailie, M., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13753 · Cited by 62
“In addition, PGE2 impedes the proliferation and migration of fibroblasts and also increases their susceptibility to apoptosis (Huang et al. 2009; Maher et al. 2010).”
BackgroundSelf-citationIncreased survivin expression contributes to apoptosis-resistance in IPF fibroblasts
Sisson, T. H., Maher, T. M., Ajayi, I. O., King, J. E., Higgins, P., Booth, A. J., Sagana, R. L., Huang, S. K., White, E. S., Moore, B. B., et al. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.326085 · Cited by 70
“Accumulating studies also show that fibrotic lung fibroblasts are resistant to a variety of apoptotic stimuli, further supporting a role for impaired fibroblast apoptosis in the pathobiology of IPF [18-25].”
BackgroundSelf-citationEpa, A. P., Thatcher, T. H., Pollock, S. J., Wahl, L. A., Lyda, E., Kottmann, R. M., Phipps, R. P., & Sime, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135266 · Cited by 61
Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface
Valatas, V., Filidou, E., Drygiannakis, I., & Kolios, G. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0146 · Cited by 69
“Furthermore, PGE2 signaling through the cAMP-coupled E prostanoid 2 and 4 receptors inhibited fibroblast proliferation and pro-collagen expression [118] and promoted fibroblast apoptosis [119].”
BackgroundBärnthaler, T., Theiler, A., Zabini, D., Trautmann, S., Stacher‐Priehse, E., Lanz, I., Klepetko, W., Sinn, K., Flick, H., Scheidl, S. J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.032 · Cited by 61
A Critical Role for the mTORC2 Pathway in Lung Fibrosis
Chang, W., Wei, K., Ho, L. A., Berry, G. J., Jacobs, S. S., Chang, C. H., & Rosen, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106155 · Cited by 56
“Since Rictor is induced by TGF-b in IPF lung fibroblasts and Akt (Ser473) phosphorylation is an mTORC2 target, we surmised that mTORC2 is a downstream target of TGF-b in IPF fibroblasts; therefore, we turned to examine if blocking mTORC2 inhibits TGF-b-mediated induction of an activated fibroblast or myofibrolast phen…”
BackgroundInfluentialRole of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids
Yin, H., Zhou, Y., Zhu, M., Hou, S., Li, Z., Zhong, H., Lu, J., Meng, T., Wang, J., Xia, L., et al. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.003 · Cited by 61
“In contrast to the anti-apoptotic properties in most cancer cells, PGE2 can induce apoptosis in human lymphocytes and in fibroblasts through multiple pathways (Huang et al., 2009; Pica et al., 1996).”
BackgroundMendoza-Milla, C., Jiménez, A. V., Rangel‐Escareño, C., Lozano, A., Morales, V., Becerril, C., Chavira, R., Ruiz, V., Barrera, L., Montaño, M., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00027412 · Cited by 56
Airway remodeling in murine asthma correlates with a defect in PGE2synthesis by lung fibroblasts
Stumm, C. L., Wettlaufer, S. H., Jancar, S., & Peters-Golden, M. L. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00158.2011 · Cited by 53
Self-citationProstaglandin E2 As an Inhibitory Modulator of Fibrogenesis in Human Lung Allografts
Walker, N., Badri, L. N., Wadhwa, A., Wettlaufer, S. H., Peters-Golden, M. L., & Lama, V. N. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0834oc · Cited by 52
“PGE2 has also been demonstrated to promote apoptosis by modulating multiple survival pathways in normal human lung fibroblasts (45).”
BackgroundSelf-citationActivated Human Lung Fibroblasts Produce Extracellular Vesicles with Antifibrotic Prostaglandins
Lacy, S. H., Woeller, C. F., Thatcher, T. H., Pollock, S. J., Small, E. M., Sime, P. J., & Phipps, R. P. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0248oc · Cited by 52
How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding?
Huang, Q., Liu, X., Critchley, H., Fu, Z., & Guo, S. (2022) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12442 · Cited by 51
Huang, S. K., Scruggs, A. M., Donaghy, J., McEachin, R. C., Fisher, A. S., Richardson, B. C., & Peters-Golden, M. L. (2012) · The FASEB Journal · doi:10.1096/fj.11-203323 · Cited by 50
“We and others have previously shown that the inhibitory effects of PGE2 on diverse lung fibroblast functions are primarily mediated via ligation of the EP2 receptor, which is the most abundantly expressed EP receptor in fibroblasts, and increased cAMP (11, 25, 30).”
BackgroundResultInfluentialSelf-citationProstaglandins antagonistically control Bax activation during apoptosis
Lalier-Bretaudeau, L., Cartron, P., Olivier, C., Logé, C., Bougras-Cartron, G., Robert, J.-M., Oliver, L., & Vallette, F. M. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.128 · Cited by 50
Lu, D., Aroonsakool, N., Yokoyama, U., Patel, H. H., & Insel, P. A. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087742 · Cited by 56
“Such phenotypic reversal is thus a potential mechanism for attenuation of abnormal wound healing responses and tissue fibrosis and occurs independent of (or in parallel with) myofibroblast apoptosis (Huang et al., 2009; Insel et al., 2012).”
Background“Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology
Horowitz, J. C., Osterholzer, J. J., Marazioti, A., & Stathopoulos, G. T. (2016) · European Respiratory Journal · doi:10.1183/13993003.01201-2015 · Cited by 45
Self-citationPenke, L. R. K., Speth, J. M., Huang, S. K., Fortier, S. M., Baas, J. D., & Peters-Golden, M. L. (2022) · JCI Insight · doi:10.1172/jci.insight.160688 · Cited by 44
“Such a mechanism is not surprising since this same signaling pathway has also been implicated in the ability of this lipid mediator to inhibit lung fibroblast collagen synthesis and differentiation to myofibroblasts, to dedifferentiate myofibroblasts, and to promote myofibroblast apoptosis (45).”
Self-citationBamberg, A., Redente, E. F., Groshong, S. D., Tuder, R. M., Cool, C. D., Keith, R. C., Edelman, B., Black, B. P., Cosgrove, G. P., Wynes, M. W., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1497oc · Cited by 44
Gabasa, M., Royo, D., Molina‐Molina, M., Roca‐Ferrer, J., Pujols, L., Picado, C., Xaubet, A., & Pereda, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065445 · Cited by 45
“PGE2 enhances epithelialmesenchymal wound healing since it improves epithelial cell survival [8], inhibits fibroblast proliferation [9], collagen I synthesis [10], cell migration [11] and cell differentiation into myofibroblasts [12], as well as inducing fibroblast apoptosis [13].”
BackgroundCosta, M. A., Fonseca, B. M., Keating, E., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2013) · Reproduction · doi:10.1530/rep-13-0563 · Cited by 49
Hasaneen, N. A., Cao, J. P., Pulkoski‐Gross, A., Zucker, S., & Foda, H. D. (2016) · Respiratory Research · doi:10.1186/s12931-016-0334-7 · Cited by 45
“Moreover, fibroblasts from fibrotic lungs are resistant to a variety of apoptotic stimuli [6, 7].”
BackgroundNara, S., Chameettachal, S., Midha, S., Murab, S., & Ghosh, S. (2016) · RSC Advances · doi:10.1039/c5ra20745b · Cited by 42
Rognoni, E., Goss, G., Hiratsuka, T., Sipilä, K. H., Kirk, T., Kober, K. I., Lui, P. P., Tsang, V., Hawkshaw, N. J., Pilkington, S. M., et al. (2021) · eLife · doi:10.7554/elife.71052 · Cited by 44
“In fibroblasts PGE-2 binding to EP4 has been shown to increase PTEN activity and Fas expression and decrease survivin expression, thereby promoting apoptosis (43).”
Fibrosis in burns: an overview of mechanisms and therapies
Faour, S., Farahat, M., Aijaz, A., & Jeschke, M. G. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00254.2023 · Cited by 47
Qin, S., Alcorn, J. F., Craigo, J. K., Tjoeng, C., Tarwater, P. M., Kolls, J. K., & Reinhart, T. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002876 · Cited by 43
Molecular determinants of mesenchymal cell activation in fibroproliferative diseases
Penke, L. R. K., & Peters-Golden, M. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03212-3 · Cited by 43
Self-citationRole of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
Kletukhina, S. K., Mutallapova, G., Андреевна, Т. А., & Gomzikova, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911212 · Cited by 40
Dietary fat and lipid metabolism in the tumor microenvironment
Goswami, S., Zhang, Q., Celik, C. E., Reich, E. M., & Yilmaz, Ö. H. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188984 · Cited by 41
PGE2 in fibrosis and cancer: Insights into fibroblast activation
Elwakeel, E., Brüne, B., & Weigert, A. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106339 · Cited by 42
Fortier, S. M., Walker, N., Penke, L. R. K., Baas, J. D., Shen, Q., Speth, J. M., Huang, S. K., Zemans, R. L., Bennett, A. M., & Peters-Golden, M. L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172826 · Cited by 40
“One such cAMP-dependent mediator is prostaglandin E 2 (PGE 2 ), which has been shown to be diminished in the lungs (56) and lung fibroblasts from patients with IPF (57) and to directly promote both MF dedifferentiation (12) and apoptosis (16, 58).”
Self-citationMatsushima, S., & Ishiyama, J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2016 · Cited by 38
Horikiri, T., Hara, H., Saito, N., Araya, J., Takasaka, N., Utsumi, H., Yanagisawa, H., Hashimoto, M., Yoshii, Y., Wakui, H., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.017 · Cited by 39
Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell
Lalier-Bretaudeau, L., Pedelaborde, F., Braud, C., Ménanteau, J., Vallette, F. M., & Olivier, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-153 · Cited by 33
“Huang and colleagues also demonstrated an EP2/EP4-mediated apoptotic role of PGE2 in fibroblasts [7].”
BackgroundLoss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
Scruggs, A. M., Koh, H. B., Tripathi, P., Leeper, N. J., White, E. S., & Huang, S. K. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0298oc · Cited by 33
Self-citationLin, Y.-C., Sung, Y. K., Jiang, X., Peters-Golden, M. L., & Nicolls, M. R. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14103 · Cited by 33
“Fibrotic lungs express less COX-2/PGE2 than healthy lungs (34).”
BackgroundSelf-citationProstanoids in Asthma and COPD
Zasłona, Z., & Peters-Golden, M. L. (2015) · CHEST Journal · doi:10.1378/chest.15-1029 · Cited by 32
Self-citationHuang, Q., Liu, X., & Guo, S. (2021) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12423 · Cited by 31
Wang, J., Li, C., Cao, Y., Wang, Q., Lu, L., Chang, H., Yan, W. S., Han, J., Wang, W., Tu, P., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0869-z · Cited by 31
“Activation of EP2/EP4 receptors by PGE2 can also promote apoptosis by increasing expressions of FasL, caspase8 and caspase9 [21].”
BackgroundVennemann, A., Gerstner, A., Kern, N., Bouzas, N. F., Narumiya, S., Maruyama, T., & Nüsing, R. M. (2012) · Diabetes · doi:10.2337/db11-1396 · Cited by 30
“Mice deficient in PARP or treated with PARP inhibitors are protected from STZ-induced b-cell death and do not develop hyperglycemia (43,44).”
BackgroundInfluentialLebender, L. F., Prünte, L., Rumzhum, N. N., & Ammit, A. J. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.01.008 · Cited by 30
Eicosanoid Control Over Antigen Presenting Cells in Asthma
Debeuf, N., & Lambrecht, B. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02006 · Cited by 27
Huang, Q., Liu, X., & Guo, S. (2021) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12426 · Cited by 28
Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation
Warsinske, H., Ashley, S. L., Linderman, J. J., Moore, B. B., & Kirschner, D. E. (2015) · Bulletin of Mathematical Biology · doi:10.1007/s11538-015-0096-2 · Cited by 26
“The outcomes vary from severe fibrosis to healthy tissue to apoptosis (Huang et al. 2009).”
Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells
Choi, S. M., Cho, Y. S., Park, G., Lee, S. K., & Chun, K. (2020) · Toxicological Research · doi:10.1007/s43188-020-00044-3 · Cited by 24
PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases
Cai, B., Liu, Y., Jung, Y. D., Zhang, Y., Liu, X., Zhao, P., & Li, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4512503 · Cited by 27
“Furthermore, PGE2 reduced survivin expression and increased Fas expression in lung fi broblasts [138].”
Mechanism of Na-K-ATPase Inhibition by PGE2 in Intestinal Epithelial Cells
Nepal, N., Arthur, S., Haynes, J., Palaniappan, B., & Sundaram, U. (2021) · Cells · doi:10.3390/cells10040752 · Cited by 23
“PGE2 has been extensively studied in the various process such as apoptosis [39] and inflammatory processes [22].”
BackgroundThe Potential Use of Cannabis in Tissue Fibrosis
Pryimak, N., Zaiachuk, M., Kovalchuk, O., & Kovalchuk, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715380 · Cited by 25
“Huang et al. (2009) HGF Fibroblast Prevents fibrosis and induces tissue repair acting through Met receptor and supporting the growth in epithelial and endothelial cells, but not in myofibroblasts.”
BackgroundLi, G., Zhang, L., Lu, Z., Yang, B., Yang, H., Shang, P., Jiang, J. X., Wang, D., & Xu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113506 · Cited by 23
“It was previously reported that low PGE2 level was observed in human pulmonary fibrosis [46] and animal models of fibrosis [47].”
BackgroundCebulla, D., van Geffen, C., & Kolahian, S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108313 · Cited by 24
Bortezomib Inhibits Lung Fibrosis and Fibroblast Activation without Proteasome Inhibition
Penke, L. R. K., Speth, J. M., Wettlaufer, S., Draijer, C., & Peters-Golden, M. L. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0112oc · Cited by 25
Self-citationSchuldt, L., Reimann, M., von Brandenstein, K., Steinmetz, J. L., Döding, A., Schulze‐Späte, U., Jacobs, C., & Symmank, J. (2022) · Cells · doi:10.3390/cells11060955 · Cited by 23
Molecular Circuits of Resolution in the Eye
Liclican, E. L., & Gronert, K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.99 · Cited by 22
“, LX), as well as regulate fibrosis[6,42,43,44,45,46,47,48].”
García-Pastor, C., Blázquez‐Serra, R., Bosch, R. J., Lucio-Cazaña, F. J., & Fernández‐Martínez, A. B. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.008 · Cited by 24
Systemic EP4 Inhibition Increases Adhesion Formation in a Murine Model of Flexor Tendon Repair
Geary, M. B., Orner, C. A., Bawany, F., Awad, H. A., Hammert, W. C., O’Keefe, R. J., & Loiselle, A. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136351 · Cited by 21
Chae, I. G., Kim, D.-H., Kundu, J. K., Jeong, C., Kundu, J. K., & Chun, K. (2014) · Free Radical Research · doi:10.3109/10715762.2014.951838 · Cited by 21
“Others have reported that ONO-AE1-329 induces apoptosis in fibroblasts [18] and inhibits cell proliferation in human airway smooth muscle cells [19] and gastric cancer cells [9], respectively.”
BackgroundProtective Role of Oryeongsan Against Renal Inflammation and Glomerulosclerosis in db/db Mice
Yoon, J. J., Lee, Y. J., Kang, D. G., & Lee, H. S. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500906 · Cited by 21
“Excessive Collagen IV deposition is an established feature associated with diabetic glomerulopathy (Huang et al., 2009).”
BackgroundOkunishi, K., DeGraaf, A. J., Zasłona, Z., & Peters-Golden, M. L. (2013) · The FASEB Journal · doi:10.1096/fj.13-231720 · Cited by 19
Self-citationProstaglandin E2 induces apoptosis in cultured rat microglia
Nagano, T., Kimura, S. H., & Takemura, M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.011 · Cited by 19
Symmank, J., Appel, S., Bastian, A., Knaup, I., Marciniak, J., Hennig, C., Döding, A., Schulze‐Späte, U., Jacobs, C., & Wolf, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116069 · Cited by 21
“Catalyzing a rate-limiting step in prostaglandin synthesis, COX2 overexpression could lead to increased production of PGE2, which was also shown to induce fibroblast apoptosis by multiple pathways [64].”
BackgroundEr, H. M., Mohamed, S., Chen, Y.-S., & Chen, J. (2015) · Biomedical Journal · doi:10.4103/2319-4170.151031 · Cited by 19
“The enhanced PGE 2 production in Fraction E–treated PMA‐activated HIG‐82 cells could have induced apoptosis in the cells, as suggested by previous studies.([22]) PMA is one of the two recommended agents to activate production of PGE 2 in HIG-82 cells.”
ResultAir pollution and diseases: signaling, G protein-coupled and Toll like receptors
Cattani‐Cavalieri, I., Ostrom, K. F., Margolis, J., Ostrom, R. S., & Schmidt, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108920 · Cited by 18
PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway
Lin, M., Lee, Y., Liao, J., Chou, C., & Yang, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70157 · Cited by 19
Wettlaufer, S. H., Penke, L. R. K., Okunishi, K., & Peters-Golden, M. L. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00131.2017 · Cited by 18
Self-citationWang, Y., Cao, R. Y., Wei, B., Chai, X., Sun, D., Guan, Y., & Liu, X. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2048-9 · Cited by 17
Intracellular prostaglandin E2 mediates cisplatin-induced proximal tubular cell death
Fernández‐Martínez, A. B., Martínez, S. B., & Lucio-Cazaña, F. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.035 · Cited by 16
Wu, Q., Zhou, Y., & Zhou, X. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1528586 · Cited by 19
Metadata
- Authors
- Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., & Peters-Golden, M.
- Affiliations
- University of Michigan (US)
- Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Michigan Medical School Ann Arbor Michigan USA
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-08-11
- Volume
- 23
- Issue
- 12
- Pages
- 4317-4326
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2812040
- OpenAlex
- W2133907923
- Cited by
- 147
- References
- 59
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 8 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 11
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- National Institutes of Health (P50 HL56402)
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- prostaglandin E2, fibroblast apoptosis, lung fibroblasts, pulmonary fibrosis, EP2 receptor, EP4 receptor, caspase-8, caspase-9, PTEN, Akt signaling, survivin, Fas ligand, interstitial lung disease, fibrogenesis
- MeSH terms
- Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Lung, Dinoprostone, Signal Transduction, Apoptosis, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.